SC
DVAX

Stephens Consulting’s Dynavax Technologies DVAX Stock Holding History

Stephens Consulting’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30
Closed -$390 – 1424
2025
Q1 		$390 Buy
+30
New +$397 ﹤0.01% 1087

Other funds holding DVAX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Stephens Consulting's DVAX Position: Q2 2025 in Review

Stephens Consulting sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 30 shares — an estimated $390 sold.

Stephens Consulting first reported a position in DVAX in Q1 2025 and held it in 1 quarter. The position peaked at $390 in Q1 2025. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Stephens Consulting reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Stephens Consulting sold 30 Dynavax Technologies shares in Q2 2025, an estimated $390.
  • Stephens Consulting first reported a position in Dynavax Technologies in Q1 2025 and held it in 1 quarter.
  • Stephens Consulting's Dynavax Technologies position peaked at $390 in Q1 2025.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.